Cargando…
Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study
BACKGROUND: Using a cross-database integrative approach, we performed an epidemiological analysis in a representative region of central Poland to evaluate the availability of radiotherapy (RTx) and overall survival of adult patients undergoing RTx for cancer. METHODS: Epidemiological data on cancer...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389344/ https://www.ncbi.nlm.nih.gov/pubmed/25884958 http://dx.doi.org/10.1186/s12885-015-1236-7 |
_version_ | 1782365539988930560 |
---|---|
author | Chalubinska-Fendler, Justyna Fendler, Wojciech Spych, Michal Luniewska-Bury, Jolanta Mlynarski, Wojciech Fijuth, Jacek |
author_facet | Chalubinska-Fendler, Justyna Fendler, Wojciech Spych, Michal Luniewska-Bury, Jolanta Mlynarski, Wojciech Fijuth, Jacek |
author_sort | Chalubinska-Fendler, Justyna |
collection | PubMed |
description | BACKGROUND: Using a cross-database integrative approach, we performed an epidemiological analysis in a representative region of central Poland to evaluate the availability of radiotherapy (RTx) and overall survival of adult patients undergoing RTx for cancer. METHODS: Epidemiological data on cancer incidence in the 2005–2012 period were obtained from the Nationwide Cancer Registry. Using data from the Ministry of Internal Affairs, we collected survival information of all patients treated in the only centre providing RTx for a region inhabited by approximately 2.6 million people. RESULTS: After filtering out individuals on the basis of exclusion criteria, the final dataset covered 17,736 patients. Availability of RTx increased marginally, from 23.5% (2005) to 24.4% (2011, R = 0.39, p = 0.38), with the highest values noted in patients with cervical (78.5%), prostate (70.6%) and breast cancer (62.7%). However, due to the decreasing population of the region, we noted increasing disparity in the likelihood of receiving RTx depending on the patient’s area of residence, with rural areas becoming progressively more neglected. The best prognosis was noted among patients with breast or prostate cancer with 5-year OS rates reaching 81.2% and 83.3%, respectively. Multivariate analysis controlling for type of diagnosis and patient age showed a time-dependent improvement in outcomes (HR(95% CI): 0.96(0.94-0.98); p < 0.0001). CONCLUSIONS: Availability of RTx in Poland is still below that reported by developed European centres. Survival of patients undergoing radical RTx has gradually improved, although it is still below that of leading RTx departments, potentially due to delayed diagnosis or organisational barriers, necessitating further investigations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1236-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4389344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43893442015-04-09 Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study Chalubinska-Fendler, Justyna Fendler, Wojciech Spych, Michal Luniewska-Bury, Jolanta Mlynarski, Wojciech Fijuth, Jacek BMC Cancer Research Article BACKGROUND: Using a cross-database integrative approach, we performed an epidemiological analysis in a representative region of central Poland to evaluate the availability of radiotherapy (RTx) and overall survival of adult patients undergoing RTx for cancer. METHODS: Epidemiological data on cancer incidence in the 2005–2012 period were obtained from the Nationwide Cancer Registry. Using data from the Ministry of Internal Affairs, we collected survival information of all patients treated in the only centre providing RTx for a region inhabited by approximately 2.6 million people. RESULTS: After filtering out individuals on the basis of exclusion criteria, the final dataset covered 17,736 patients. Availability of RTx increased marginally, from 23.5% (2005) to 24.4% (2011, R = 0.39, p = 0.38), with the highest values noted in patients with cervical (78.5%), prostate (70.6%) and breast cancer (62.7%). However, due to the decreasing population of the region, we noted increasing disparity in the likelihood of receiving RTx depending on the patient’s area of residence, with rural areas becoming progressively more neglected. The best prognosis was noted among patients with breast or prostate cancer with 5-year OS rates reaching 81.2% and 83.3%, respectively. Multivariate analysis controlling for type of diagnosis and patient age showed a time-dependent improvement in outcomes (HR(95% CI): 0.96(0.94-0.98); p < 0.0001). CONCLUSIONS: Availability of RTx in Poland is still below that reported by developed European centres. Survival of patients undergoing radical RTx has gradually improved, although it is still below that of leading RTx departments, potentially due to delayed diagnosis or organisational barriers, necessitating further investigations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1236-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-02 /pmc/articles/PMC4389344/ /pubmed/25884958 http://dx.doi.org/10.1186/s12885-015-1236-7 Text en © Chalubinska-Fendler et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Chalubinska-Fendler, Justyna Fendler, Wojciech Spych, Michal Luniewska-Bury, Jolanta Mlynarski, Wojciech Fijuth, Jacek Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study |
title | Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study |
title_full | Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study |
title_fullStr | Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study |
title_full_unstemmed | Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study |
title_short | Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study |
title_sort | availability and outcomes of radiotherapy in central poland during the 2005-2012 period - an observational study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389344/ https://www.ncbi.nlm.nih.gov/pubmed/25884958 http://dx.doi.org/10.1186/s12885-015-1236-7 |
work_keys_str_mv | AT chalubinskafendlerjustyna availabilityandoutcomesofradiotherapyincentralpolandduringthe20052012periodanobservationalstudy AT fendlerwojciech availabilityandoutcomesofradiotherapyincentralpolandduringthe20052012periodanobservationalstudy AT spychmichal availabilityandoutcomesofradiotherapyincentralpolandduringthe20052012periodanobservationalstudy AT luniewskaburyjolanta availabilityandoutcomesofradiotherapyincentralpolandduringthe20052012periodanobservationalstudy AT mlynarskiwojciech availabilityandoutcomesofradiotherapyincentralpolandduringthe20052012periodanobservationalstudy AT fijuthjacek availabilityandoutcomesofradiotherapyincentralpolandduringthe20052012periodanobservationalstudy |